cyc 202 has been researched along with Mesothelioma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, YY; Chuan-Hao Kao, S; Gattani, S; Griggs, K; Kirschner, MB; Klebe, S; Linton, A; McCaughan, BC; Reid, G; Schedlich, L; Srikaran, S; van Zandwijk, N | 1 |
1 other study(ies) available for cyc 202 and Mesothelioma
Article | Year |
---|---|
An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma.
Topics: Apoptosis; Blood Proteins; CDC2 Protein Kinase; Cell Cycle; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Cisplatin; Cytoskeletal Proteins; DNA Repair; DNA Replication; Humans; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Molecular Targeted Therapy; Nuclear Proteins; Pleural Neoplasms; Polo-Like Kinase 1; Prognosis; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Purines; Retrospective Studies; RNA Interference; Roscovitine | 2014 |